Literature DB >> 2174891

Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.

A R Mackay1, J L Hartzler, M D Pelina, U P Thorgeirsson.   

Abstract

Two major gelatinolytic metalloproteinases (gelatinases) of 65 kDa and 92 kDa were purified from a tumor cell line. Analysis of collagen degradation showed that native full-length Engelbreth-Holm-Swarm (EHS) type IV collagen was not cleaved by the purified gelatinases under conditions where native pepsin-extracted human placental type IV and V collagen and heat-denatured collagens were markedly degraded. However, EHS type IV collagen degradation was noted at 37 degrees C, i.e., under conditions that would favor denaturation of the collagen molecule in solution. The pattern of degradation of human placental type IV and V collagen appeared similar for both gelatinases. Zymogram analysis of gelatinase activity in the absence of sodium dodecyl sulfate (SDS) (to eliminate possible SDS-mediated denaturation of type IV collagen) confirmed the inability of 65 and 92-kDa gelatinases to degrade native full-length EHS type IV collagen. Under the same conditions and in SDS-polyacrylamide gel electrophoresis zymograms the gelatinases degraded pepsin-predigested EHS type IV collagen and pepsin-extracted human placental type IV collagen. These data suggest that the 65- and 92-kDa tumor cell gelatinases are not true type IV collagenases. Their ability to degrade pepsin-solubilized, or denatured, type IV collagen suggests a specificity for telopeptide precleaved or conformationally altered forms of this molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174891

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.

Authors:  M Ballin; A R Mackay; J L Hartzler; A Nason; M D Pelina; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

Authors:  G Murphy; M I Cockett; R V Ward; A J Docherty
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.

Authors:  Susanna Monaco; Valentina Sparano; Magda Gioia; Diego Sbardella; Donato Di Pierro; Stefano Marini; Massimo Coletta
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

Review 4.  Control of matrix metalloproteinase catalytic activity.

Authors:  Hyun-Jeong Ra; William C Parks
Journal:  Matrix Biol       Date:  2007-07-07       Impact factor: 11.583

5.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

6.  Age-related changes in the expression of gelatinase and tissue inhibitor of metalloproteinase genes in mandibular condylar, growth plate, and articular cartilage in rats.

Authors:  Ichiro Takahashi; Kazuyuki Onodera; Jin-Wan Bae; Hidetoshi Mitani; Yasuyuki Sasano; Hideo Mitani
Journal:  J Mol Histol       Date:  2005-10-06       Impact factor: 2.611

7.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A).

Authors:  L Bányai; H Tordai; L Patthy
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

Review 9.  Matrix metalloproteases and lung disease.

Authors:  C M O'Connor; M X FitzGerald
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

10.  In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.

Authors:  David Pretzel; Dirk Pohlers; Sönke Weinert; Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2009-02-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.